ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,330,000 | -16.9% | 32,089 | -3.8% | 0.02% | -10.7% |
| Q4 2021 | $2,805,000 | -7.6% | 33,361 | -0.8% | 0.03% | -6.7% |
| Q3 2021 | $3,035,000 | +1.6% | 33,646 | +7.5% | 0.03% | +3.4% |
| Q2 2021 | $2,986,000 | -35.6% | 31,311 | -23.1% | 0.03% | -40.8% |
| Q1 2021 | $4,639,000 | -22.1% | 40,743 | -5.2% | 0.05% | -27.9% |
| Q4 2020 | $5,952,000 | +65.0% | 42,997 | -2.1% | 0.07% | +41.7% |
| Q3 2020 | $3,608,000 | +40.3% | 43,904 | +33.6% | 0.05% | +33.3% |
| Q2 2020 | $2,571,000 | +60.8% | 32,868 | -8.7% | 0.04% | +33.3% |
| Q1 2020 | $1,599,000 | -0.2% | 35,988 | -4.1% | 0.03% | +35.0% |
| Q4 2019 | $1,603,000 | -0.8% | 37,532 | -0.7% | 0.02% | -9.1% |
| Q3 2019 | $1,616,000 | -33.0% | 37,784 | -0.5% | 0.02% | -35.3% |
| Q2 2019 | $2,412,000 | -8.4% | 37,989 | +0.1% | 0.03% | -10.5% |
| Q1 2019 | $2,633,000 | +62.4% | 37,964 | +1.8% | 0.04% | +40.7% |
| Q4 2018 | $1,621,000 | -42.8% | 37,293 | +0.4% | 0.03% | -32.5% |
| Q3 2018 | $2,835,000 | -2.1% | 37,143 | -1.4% | 0.04% | -7.0% |
| Q2 2018 | $2,895,000 | +49.8% | 37,660 | -0.7% | 0.04% | +43.3% |
| Q1 2018 | $1,933,000 | +11.5% | 37,910 | +1.5% | 0.03% | +15.4% |
| Q4 2017 | $1,733,000 | -13.3% | 37,360 | -0.4% | 0.03% | -21.2% |
| Q3 2017 | $1,998,000 | -14.2% | 37,507 | 0.0% | 0.03% | -17.5% |
| Q2 2017 | $2,330,000 | -10.3% | 37,507 | -2.1% | 0.04% | -13.0% |
| Q1 2017 | $2,597,000 | +10.3% | 38,320 | +14.4% | 0.05% | +4.5% |
| Q4 2016 | $2,354,000 | -1.4% | 33,483 | -0.5% | 0.04% | -8.3% |
| Q3 2016 | $2,387,000 | +45.0% | 33,647 | 0.0% | 0.05% | +37.1% |
| Q2 2016 | $1,646,000 | -22.7% | 33,647 | 0.0% | 0.04% | -25.5% |
| Q1 2016 | $2,130,000 | -43.3% | 33,647 | +0.4% | 0.05% | -44.0% |
| Q4 2015 | $3,758,000 | +18.3% | 33,497 | +1.5% | 0.08% | +12.0% |
| Q3 2015 | $3,178,000 | +210.4% | 33,000 | +230.0% | 0.08% | +240.9% |
| Q2 2015 | $1,024,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |